Revisiting the thrifty substrate hypothesis: Ketone bodies as cardioprotective fuels in diabetes and SGLT2 inhibitor therapy
Journal of Diabetes Investigation · 2025-07 · 16 (7) · 1154-1156
DOI: 10.1111/jdi.70068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 07.05.2025. Verfasst von Yoriyasu Suzuki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aichi Medical University, Nagakute, Aichi, Japan. Hauptthemen laut MEDLINE: Cardiotonic Agents, Diabetes Mellitus, Type 2, Heart Failure, Ketone Bodies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Aichi Medical University, Nagakute, Aichi, Japan.
ORCID-Profile: Yoriyasu Suzuki
Zitieren
APA
Suzuki, Y., & Amano, T. (2025). Revisiting the thrifty substrate hypothesis: Ketone bodies as cardioprotective fuels in diabetes and SGLT2 inhibitor therapy. Journal of Diabetes Investigation, 16(7), 1154-1156. https://doi.org/10.1111/jdi.70068
Vancouver
Suzuki Y, Amano T. Revisiting the thrifty substrate hypothesis: Ketone bodies as cardioprotective fuels in diabetes and SGLT2 inhibitor therapy. Journal of Diabetes Investigation. 2025;16(7):1154-1156. doi:10.1111/jdi.70068
BibTeX
@article{Suzuki2025,
author = {Suzuki, Yoriyasu and Amano, Tetsuya},
title = {Revisiting the thrifty substrate hypothesis: Ketone bodies as cardioprotective fuels in diabetes and SGLT2 inhibitor therapy},
journal = {Journal of Diabetes Investigation},
year = {2025},
volume = {16},
number = {7},
pages = {1154--1156},
doi = {10.1111/jdi.70068}
}
EUVIMED